Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026)

Mineralys Therapeutics (MLYS) reported EPS (Basic) of -$0.55 for Q1 2026, up 34.53% on a YoY basis from -$0.41 in Q1 2025, and up 79.94% sequentially from -$2.73 in Q4 2025.

Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026) Analysis & Trends

Mineralys Therapeutics (MLYS) has 5 years of EPS (Basic) data on file, last reported at -$0.55 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 34.53% year-over-year to -$0.55; the trailing twelve-month figure through Mar 2026 stood at -$3.84 (up 27.52% YoY), and the FY2025 full-year result was -$4.68, up 16.51% from the prior year.
  • EPS (Basic) rose to -$0.55 in Q1 2026, from -$2.73 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.4 in Q2 2023 to a low of -$4.95 in Q4 2022.
  • A 5-year average of -$1.33 and a median of -$0.84 in 2025 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) surged 84.05% in 2023 and sank 243.69% in 2024, its largest moves.
  • Tracing MLYS's EPS (Basic) over 5 years: stood at -$4.95 in 2022, then surged by 84.05% to -$0.79 in 2023, then tumbled by 243.69% to -$2.71 in 2024, then fell by 0.57% to -$2.73 in 2025, then jumped by 79.94% to -$0.55 in 2026.
  • Business Quant data shows MLYS's EPS (Basic) at -$0.55 in Q1 2026, -$2.73 in Q4 2025, and -$0.58 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Mineralys Therapeutics 2.24 Bn 2.24 Bn - -0.55

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.55
Dec 31, 2025 -2.73
Sep 30, 2025 -0.58
Jun 30, 2025 -0.71
Mar 31, 2025 -0.84
Dec 31, 2024 -2.71
Sep 30, 2024 -1.21
Jun 30, 2024 -0.92
Mar 31, 2024 -0.79
Dec 31, 2023 -0.79
Sep 30, 2023 -0.66
Jun 30, 2023 -0.40
Mar 31, 2023 -0.60
Dec 31, 2022 -4.95
Sep 30, 2022 -1.43
Jun 30, 2022 -1.26
Mar 31, 2022 -1.48